Look for:

Our offer for

KONINKLIJKE DSM NV


ISIN:
NL0000009827
WKN:
-
- -
Price
-
Difference - (-)

General attributes

ISINNL0000009827
Symbol8010908149
Exchange-
Currency-
SectorConsumer Products
Security typeStock
Market cap (m)764 EUR
BenchmarkAMSTERDAM EXCHANGES INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open-
High-
Low-
Close (prev. day)-
VWAP-
Volume (pcs)-
Trading volume-
Number of trades-
Last size-

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: KONINKLIJKE DSM NVPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



- -
Price
-
Difference - (-)

General attributes

ISINNL0000009827
Symbol8010908149
Exchange-
Currency-
SectorConsumer Products
Security typeStock
Market cap (m)764 EUR
BenchmarkAMSTERDAM EXCHANGES INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open-
High-
Low-
Close (prev. day)-
VWAP-
Volume (pcs)-
Trading volume-
Number of trades-
Last size-

Performance and Risk

6m1Y3Y
Perf (%)-5.84%-21.55%-1.60%
Perf (abs.)-7.05-31.25-1.85
Beta0.00-0.120.06
Volatility26.1331.9726.71
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)112.67 - (5)
Ø price 30 days | Ø volume 30 days (pcs.)115.15 - (15)
Ø price 100 days | Ø volume 100 days (pcs.)116.68 - (89)
Ø price 250 days | Ø volume 250 days (pcs.)124.39 - (51)
YTD High | date125.35 - (2023/02/09)
YTD Low | date106.25 - (2023/03/31)
52 Weeks High | date162.55 - (2022/05/31)
52 Weeks Low | date106.25 - (2023/03/31)

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2267&ID_TYPE_IMAGE_LOGO=2

Contact Details

DSM NV
- -
Het Overloon 1 - 6411 TE Heerlen
Telefon: +(310) 455-7881
Fax: +
E-mail: social.media@dsm.com

PDF Downloads

Company report: KONINKLIJKE DSM NVPDF Download

Company Profile

Koninklijke DSM NV engages in the manufacture and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. It operates through the following segments: Nutrition, Materials, Innovation Center, and Corporate Activities. The Nutrition segment serves the global industries for animal feed, food and beverage, pharmaceuticals, infant nutrition, dietary supplements, and personal care. The Materials segment deals with specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. The Innovation Center segment focuses on innovation and the growth of DSM's existing core business through adjacent technologies. The Corporate Activities segment consists of operating and service activities as well as other several costs. The company was founded in 1902 and is headquartered in Herleen, the Netherlands.

Members of Management Board

Dimitri de VreezeMember of Executive Committee
Geraldine MatchettMember of Executive Committee

Board of directors

Thomas LeysenChairman of Supervisory Board
Eileen KennedyMember of Supervisory Board
Carla M. C. MahieuMember of Supervisory Board
Corien Wortmann-KoolMember of Supervisory Board
Erica MannMember of Supervisory Board
Frits van PaasschenMember of Supervisory Board
John RamsayMember of Supervisory Board
Pradeep PantMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer